Tower Research Capital (TRC)’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,972
| Closed | -$12K | – | 7222 |
|
|
2021
Q4 | $12K | Sell |
3,972
-23,793
| -86% | -$80.1K | ﹤0.01% | 4375 |
|
|
2021
Q3 | $100K | Buy |
27,765
+20,289
| +271% | +$76.5K | ﹤0.01% | 2404 |
|
|
2021
Q2 | $27K | Sell |
7,476
-2,598
| -26% | -$9.16K | ﹤0.01% | 3627 |
|
|
2021
Q1 | $39K | Sell |
10,074
-6,498
| -39% | -$26.8K | ﹤0.01% | 3347 |
|
|
2020
Q4 | $70K | Sell |
16,572
-87,487
| -84% | -$337K | ﹤0.01% | 2733 |
|
|
2020
Q3 | $388K | Buy |
104,059
+82,806
| +390% | +$352K | ﹤0.01% | 1961 |
|
|
2020
Q2 | $92K | Buy |
21,253
+21,153
| +21,153% | +$95.1K | ﹤0.01% | 2539 |
|
|
2020
Q1 | $0 | Buy |
+100
| New | +$491 | ﹤0.01% | 4483 |
|
|
2019
Q4 | – | Sell |
-927
| Closed | -$4K | – | 4918 |
|
|
2019
Q3 | $4K | Sell |
927
-773
| -45% | -$3.3K | ﹤0.01% | 3510 |
|
|
2019
Q2 | $8K | Sell |
1,700
-10,206
| -86% | -$47.5K | ﹤0.01% | 2743 |
|
|
2019
Q1 | $63K | Buy |
11,906
+10,055
| +543% | +$45.9K | ﹤0.01% | 1660 |
|
|
2018
Q4 | $7K | Buy |
+1,851
| New | +$6.5K | ﹤0.01% | 2761 |
|
|
2018
Q2 | – | Sell |
-128
| Closed | – | – | 4461 |
|
|
2018
Q1 | $0 | Buy |
+128
| New | +$300 | ﹤0.01% | 4313 |
|
|
2016
Q4 | – | Sell |
-1,299
| Closed | -$4K | – | 4996 |
|
|
2016
Q3 | $4K | Buy |
+1,299
| New | +$3.3K | ﹤0.01% | 2789 |
|
|
2016
Q2 | – | Sell |
-1,970
| Closed | -$7K | – | 5546 |
|
|
2016
Q1 | $7K | Sell |
1,970
-10,514
| -84% | -$38.9K | ﹤0.01% | 2482 |
|
|
2015
Q4 | $60K | Buy |
12,484
+8,177
| +190% | +$46.4K | 0.01% | 476 |
|
|
2015
Q3 | $24K | Sell |
4,307
-19,349
| -82% | -$143K | ﹤0.01% | 1599 |
|
|
2015
Q2 | $188K | Buy |
23,656
+23,456
| +11,728% | +$202K | 0.02% | 406 |
|
|
2015
Q1 | $2K | Buy |
+200
| New | +$2.73K | ﹤0.01% | 3960 |
|
|
2014
Q4 | – | Sell |
-5,685
| Closed | -$97K | – | 5521 |
|
|
2014
Q3 | $97K | Buy |
+5,685
| New | +$82.5K | 0.01% | 1007 |
|
|
2014
Q1 | – | Sell |
-2,564
| Closed | -$15K | – | 5551 |
|
|
2013
Q4 | $15K | Buy |
2,564
+2,377
| +1,271% | +$12.3K | ﹤0.01% | 2653 |
|
|
2013
Q3 | $1K | Sell |
187
-14,962
| -99% | -$71.9K | ﹤0.01% | 4491 |
|
|
2013
Q2 | $62K | Buy |
+15,149
| New | +$71.1K | 0.01% | 793 |
|
Other funds holding BDSI
Tower Research Capital (TRC)'s BDSI Position: Q1 2022 in Review
Tower Research Capital (TRC) sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 3,972 shares — an estimated $12K sold.
Tower Research Capital (TRC) first reported a position in BDSI in Q2 2013 and held it in 23 quarters. The position peaked at $388K in Q3 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Tower Research Capital (TRC) reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 3,972 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $12K.
- Tower Research Capital (TRC) first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 23 quarters.
- Tower Research Capital (TRC)'s BioDelivery Sciences International, Inc. position peaked at $388K in Q3 2020.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.